4//SEC Filing
ESSEX WOODLANDS HEALTH VENTURES FUND VI L P 4
Accession 0001181431-09-038509
CIK 0000920465other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:45 PM ET
Size
7.1 KB
Accession
0001181431-09-038509
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2009-08-06$0.18/sh−368,872$67,614→ 0 total - Sale
Common Stock
2009-08-05$0.19/sh−792,942$148,439→ 368,872 total
Footnotes (2)
- [F1]Represents the weighted average sale price of shares purchased by the Reporting Person in the price range of $0.181 to $0.195. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]Represents the weighted average sale price of shares purchased by the Reporting Person in the price range of $0.1800 to $0.1890. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001276801
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 4:45 PM ET
- Size
- 7.1 KB